Research Article

Evaluation of Percutaneous Tracheostomy Cases at An Tertiary Care Center Intensive Care Unit

Volume: 3 Number: 3 December 31, 2019
EN TR

Evaluation of Percutaneous Tracheostomy Cases at An Tertiary Care Center Intensive Care Unit

Abstract

Aim: Percutaneous tracheostomy is frequently performed in intensive care units, especially in patients requiring long-term mechanical ventilatory support.  It has advantages such as providing safe airway, facilitating the aspiration of the airways and reducing the length of stay in the intensive care unit. In this study, we aimed to retrospectively evaluate the percutaneous tracheostomy cases that we opened with the seldinger method at a tertiary care center intensive care unit.

Materials and Methods: Our study was performed retrospectively. The records of 78 patients who underwent percutaneous tracheostomy between June 15, 2016 and August 30, 2018 were included. Patients with surgical and local infection at the intervention site, short neck and large thyroid tissue, cervical vertebra fracture or neck extension restriction, morbid obese and patients under 18 years of age were excluded from the study.

Results: 78 patients were included in our study. the mean length of stay in the ICU was 39 days; mean duration of tracheostomy was 16.3 days. Most of the patients were admitted to intensive care unit due to serbrovascular and cardiovascular diseases. . Hypotension was detected in four patients after tracheostomy, while wound infection and subcutaneous emphysema were found in one patient.

Conclusion: Percutaneous tracheostomy is an easy method that can be applied to bedside in a short time in patients who need mechanical ventilation for a long time. Intubation and prolonged mechanical ventilator is a useful method that is frequently used in intensive care patients because it reduces side effects, improves patient comfort and facilitates patient care. Complications can be minimized if appropriate patient selection is performed by an experienced physician.

Keywords

Supporting Institution

yok

Thanks

yok

References

  1. 1. Friedman Y. Percutaneous versus surgical tracheostomy: The continuing saga. Crit Care Med 2006; 34(8): 2250-1
  2. 2. Kost KM. Endoscopic percutaneous dilatational tracheotomy: a prospective evaluation of 500 consecutive cases. Laryngoscope 2005; 115: 1-30.
  3. 3. Sağıroğlu AE, Ağkoç E, Doğan Y, et al. Comparison of percutaneus and surgical tracheos- tomy in ICU [Article in Turkish]. Göztepe Tıp Dergisi 2010;25:67–70
  4. 4. Al-Ansari MA, Hijazi MH. Clinical review: percutaneous dilatational tracheostomy. Crit Care 2006; 10: 202.
  5. 5. Cabrini L, Bergonzi PC, Mamo D, et al. Dilatative percutaneous tracheostomy during doub- le antiplatelet therapy: two consecutive cases. Minerva Anestesiol 2008; 74: 565-7.
  6. 6. Friedman Y. Percutaneous versus surgical tracheostomy: The continuing saga. Crit Care Med 2006; 34(8): 2250-1
  7. 7. Rumbak MJ, Newton M, Truncale T,et al. A prospective, randomized, study comparing early percutaneous dilational tracheotomy to prolonged translaryngeal intubation (delayed tracheotomy) in critically ill medical patients. Crit Care Med 2004; 32: 1689-94.
  8. 8. Yıldırım F , Güllü YT, Demirel CB. Yoğun Bakımda Perkütan Trakeostomi. Eurasian J Pulmonol 2015 DOI: 10.5152/ejp.2014.27247.

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Publication Date

December 31, 2019

Submission Date

November 18, 2019

Acceptance Date

November 28, 2019

Published in Issue

Year 2019 Volume: 3 Number: 3

APA
Ece, C. (2019). Evaluation of Percutaneous Tracheostomy Cases at An Tertiary Care Center Intensive Care Unit. Journal of Biotechnology and Strategic Health Research, 3(3), 245-249. https://doi.org/10.34084/bshr.647658
AMA
1.Ece C. Evaluation of Percutaneous Tracheostomy Cases at An Tertiary Care Center Intensive Care Unit. J Biotechnol and Strategic Health Res. 2019;3(3):245-249. doi:10.34084/bshr.647658
Chicago
Ece, Cem. 2019. “Evaluation of Percutaneous Tracheostomy Cases at An Tertiary Care Center Intensive Care Unit”. Journal of Biotechnology and Strategic Health Research 3 (3): 245-49. https://doi.org/10.34084/bshr.647658.
EndNote
Ece C (December 1, 2019) Evaluation of Percutaneous Tracheostomy Cases at An Tertiary Care Center Intensive Care Unit. Journal of Biotechnology and Strategic Health Research 3 3 245–249.
IEEE
[1]C. Ece, “Evaluation of Percutaneous Tracheostomy Cases at An Tertiary Care Center Intensive Care Unit”, J Biotechnol and Strategic Health Res, vol. 3, no. 3, pp. 245–249, Dec. 2019, doi: 10.34084/bshr.647658.
ISNAD
Ece, Cem. “Evaluation of Percutaneous Tracheostomy Cases at An Tertiary Care Center Intensive Care Unit”. Journal of Biotechnology and Strategic Health Research 3/3 (December 1, 2019): 245-249. https://doi.org/10.34084/bshr.647658.
JAMA
1.Ece C. Evaluation of Percutaneous Tracheostomy Cases at An Tertiary Care Center Intensive Care Unit. J Biotechnol and Strategic Health Res. 2019;3:245–249.
MLA
Ece, Cem. “Evaluation of Percutaneous Tracheostomy Cases at An Tertiary Care Center Intensive Care Unit”. Journal of Biotechnology and Strategic Health Research, vol. 3, no. 3, Dec. 2019, pp. 245-9, doi:10.34084/bshr.647658.
Vancouver
1.Cem Ece. Evaluation of Percutaneous Tracheostomy Cases at An Tertiary Care Center Intensive Care Unit. J Biotechnol and Strategic Health Res. 2019 Dec. 1;3(3):245-9. doi:10.34084/bshr.647658

Journal of Biotechnology and Strategic Health Research